Top Health Officials Meet to Discuss Pause of Johnson & Johnson Vaccine

Dr. Jonathan Javitt, CEO of NeuroRx and adjunct professor at Johns Hopkins School of Medicine, discusses the pause of the Johnson & Johnson Covid-19 vaccine and other coronavirus developments.
close
We use cookies and similar technologies on this site to collect identifiers, such as IP address, and cookie and device IDs as described in our Privacy Policy.